EPCAM and hepatocellular carcinoma: Doxorubicin increased the expression of stemness-related genes, such as epithelial cell adhesion molecule (EpCAM), cytoskeletal 19 (CK19), annexin A3 (ANXA3), and the multidrug-resistance-related gene ABCG2 in hepatocellular carcinoma cells (HCCs) [71].